Market Overview:
The global keloid treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of keloids, increasing awareness about available treatments, and technological advancements in keloid treatment methods. Based on type, the occlusive dressing segment is expected to account for the largest share of the global keloid treatment market in 2018. This segment is projected to grow at a CAGR of 6.1% from 2018 to 2030. The large share of this segment can be attributed to the high efficacy and low cost associated with occlusive dressings compared with other treatments for keloids. Based on application, hospitals are expected to account for the largest share of the global Keloid Treatment Market in 2018 followed by dermatology clinics.
Product Definition:
The treatment of a keloid is not always necessary, but there are a few things you can do to help reduce the size or appearance of a keloid. If the keloid is causing pain or discomfort, your doctor may recommend surgery to remove it.
-Corticosteroids: These medications can help reduce inflammation and shrink the size of a keloid. They may be injected directly into the lesion, applied as a cream, ointment, gel, lotion or spray, or taken orally.
-Interferon alfa-2b: This medication can also help reduce inflammation and shrink the size of a keloid. It is often injected directly into the lesion.
-Cryotherapy: This involves freezing the lesion with liquid nitrogen in order to destroy its cells and cause it to collapse. It is usually used for smaller lesions that are less than 1 cm in diameter.
Occlusive Dressing:
Ooclusive dressing is a medical term used for the application of dressings that cover the entire wound and do not allow any external air to come in contact with it. Ooclusive dressing includes two types of materials namely non-adherent and adhering films or sheets. These products are generally made up of hydrocolloids such as carboxy methylcellulose (CMC) or hydroxypropyl methyl cellulose (HPMC).
Compression Therapy:
Compression therapy is a technique that involves the use of bandages or garments to reduce swelling and inflammation. Compression therapy is used in the treatment of keloid (a raised, bumpy, red scar) and other types of chronic wounds. It helps to decrease pain and promotes healing by reducing cellular activity in the body.
Application Insights:
The others segment held the largest share of the application market in 2017. This segment includes surgical excisions, chemical peels, and physical modalities such as massage and hydrotherapy. Surgical excision is one of the most common methods used for keloid treatment due to its minimal invasive procedure with high success rate. However, this method is only applicable for localised or non-invasive types of keloids.
Chemical peel holds significant potential in treating various types of scars including hypertrophic and contracture scars along with Keloids as it reduces inflammation & pain caused by these lesions at cellular level by triggering natural healing process known as ¢â‚¬Å“ apoptosis¢â‚¬ which results in reduction in size & prominence of scar tissue over a period ranging from 1 to 6 months after injury has healed completely.
Regional Analysis:
North America held the largest revenue share in 2017. The region is expected to maintain its dominance throughout the forecast period owing to increasing awareness about keloid treatment and availability of advanced technologies for treating it. In addition, rising incidence of skin-related disorders due to increased exposure to UV rays is anticipated to fuel market growth over the forecast period.
Asia Pacific is estimated be fastest growing region during the forecast years due with developing healthcare infrastructure, economic development and increase in disposable income especially in countries such as India & China & South Korea which has led rise in incidence of skin-related disorders such as keloids & hypertrophic scars resulting into high unmet needs for Keloid Treatment Market that can provide solutions effectively through innovation.
Growth Factors:
- Increasing incidence of keloid disorder
- Growing awareness about available treatment options for keloids
- Rising demand for minimally invasive procedures
- Technological advancements in keloid treatment procedures
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Keloid Treatment Market Research Report
By Type
Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injection, Others
By Application
Hospitals, Dermatology Clinics, Ambulatory Surgical Centres, Others
By Companies
Novartis, Xylem Inc, RXi, Sonoma, Perrigo, Bristol-Myers Squibb, Pacific World, Valeant, Revitol, Avita
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Keloid Treatment Market Report Segments:
The global Keloid Treatment market is segmented on the basis of:
Types
Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injection, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Dermatology Clinics, Ambulatory Surgical Centres, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Xylem Inc
- RXi
- Sonoma
- Perrigo
- Bristol-Myers Squibb
- Pacific World
- Valeant
- Revitol
- Avita
Highlights of The Keloid Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Occlusive Dressing
- Compression Therapy
- Cryosurgery
- Excision
- Radiation Therapy
- Laser Therapy
- Interferon Therapy
- Intralesional Corticosteroid Injection
- Others
- By Application:
- Hospitals
- Dermatology Clinics
- Ambulatory Surgical Centres
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Keloid Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Keloid treatment is a surgical procedure to remove the scar tissue that forms from keloids. Keloids are benign tumors that can form on any part of the body, but they are most commonly found on the skin. Keloids can grow quickly and cause pain, inflammation, and deformity. They may also be difficult to treat because they often recur after surgery.
Some of the major companies in the keloid treatment market are Novartis, Xylem Inc, RXi, Sonoma, Perrigo, Bristol-Myers Squibb, Pacific World, Valeant, Revitol, Avita.
The keloid treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Keloid Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Keloid Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Keloid Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Keloid Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Keloid Treatment Market Size & Forecast, 2020-2028
4.5.1 Keloid Treatment Market Size and Y-o-Y Growth
4.5.2 Keloid Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Occlusive Dressing
5.2.2 Compression Therapy
5.2.3 Cryosurgery
5.2.4 Excision
5.2.5 Radiation Therapy
5.2.6 Laser Therapy
5.2.7 Interferon Therapy
5.2.8 Intralesional Corticosteroid Injection
5.2.9 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Dermatology Clinics
6.2.3 Ambulatory Surgical Centres
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Keloid Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Keloid Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Occlusive Dressing
9.6.2 Compression Therapy
9.6.3 Cryosurgery
9.6.4 Excision
9.6.5 Radiation Therapy
9.6.6 Laser Therapy
9.6.7 Interferon Therapy
9.6.8 Intralesional Corticosteroid Injection
9.6.9 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Dermatology Clinics
9.10.3 Ambulatory Surgical Centres
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Occlusive Dressing
10.6.2 Compression Therapy
10.6.3 Cryosurgery
10.6.4 Excision
10.6.5 Radiation Therapy
10.6.6 Laser Therapy
10.6.7 Interferon Therapy
10.6.8 Intralesional Corticosteroid Injection
10.6.9 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Dermatology Clinics
10.10.3 Ambulatory Surgical Centres
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Occlusive Dressing
11.6.2 Compression Therapy
11.6.3 Cryosurgery
11.6.4 Excision
11.6.5 Radiation Therapy
11.6.6 Laser Therapy
11.6.7 Interferon Therapy
11.6.8 Intralesional Corticosteroid Injection
11.6.9 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Dermatology Clinics
11.10.3 Ambulatory Surgical Centres
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Occlusive Dressing
12.6.2 Compression Therapy
12.6.3 Cryosurgery
12.6.4 Excision
12.6.5 Radiation Therapy
12.6.6 Laser Therapy
12.6.7 Interferon Therapy
12.6.8 Intralesional Corticosteroid Injection
12.6.9 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Dermatology Clinics
12.10.3 Ambulatory Surgical Centres
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Occlusive Dressing
13.6.2 Compression Therapy
13.6.3 Cryosurgery
13.6.4 Excision
13.6.5 Radiation Therapy
13.6.6 Laser Therapy
13.6.7 Interferon Therapy
13.6.8 Intralesional Corticosteroid Injection
13.6.9 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Dermatology Clinics
13.10.3 Ambulatory Surgical Centres
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Keloid Treatment Market: Competitive Dashboard
14.2 Global Keloid Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Xylem Inc
14.3.3 RXi
14.3.4 Sonoma
14.3.5 Perrigo
14.3.6 Bristol-Myers Squibb
14.3.7 Pacific World
14.3.8 Valeant
14.3.9 Revitol
14.3.10 Avita
